Okla. Jury Slams Allergan With $15M Botox Verdict

Law360, New York (May 13, 2010, 7:13 PM EDT) -- An Oklahoma state jury has hit Allergan Inc., the maker of wrinkle-treating drug Botox, with a $15 million verdict in a suit brought by a woman alleging she got sick after receiving injections of the drug.

"We believe this is the first case in the nation in which the jury has found that botulism-type symptoms have been caused by Botox," Anton Rupert, an attorney at Crowe & Dunlevy who represents the plaintiff, said in a statement Wednesday.

The plaintiff, Dr. Sharla Helton, was an obstetrician and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.